phase readout
saveNCT05089084: Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)
COMPLETEDupdated 1d ago
community read0 votes
Sponsor: Arrowhead Pharmaceuticals. Phase: PHASE3. Conditions: Familial Chylomicronemia
view source ↗
comments(0)
5-min edit window · permanent after that